2021
DOI: 10.1007/s10517-021-05177-5
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Low-Molecular-Weight Allosteric Agonist of Luteinizing Hormone Receptor on Functional State of the Testes in Aging and Diabetic Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…We have developed a series of thieno[2,3-d]-pyrimidine derivatives with the properties of allosteric agonists and (or) ago-PAMs and allosteric antagonists of LHR [ 324 , 325 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 ]. Compounds TP03 and TP04, the most active of the full agonists, stimulated the AC activity in testicular membranes isolated from the rat testes, increased testosterone production by the cultured Leydig cells, and also stimulated testicular steroidogenesis and increased testosterone levels when administered intraperitoneally, subcutaneously, and orally to both healthy male rats and animals with androgen deficiency caused by types 1 and 2 diabetes mellitus and aging [ 395 , 400 , 402 , 403 , 404 ]. Using molecular docking, it was found that the efficiency and selectivity of the studied thieno[2,3-d]-pyrimidines correlate with the characteristics of their binding to the transmembrane allosteric site of LHR, and the key parameter of such binding was the intensity of hydrophobic contact while the Coulomb interactions and hydrogen bonds were less significant [ 400 ].…”
Section: Allosteric Regulators Of Pituitary Glycoprotein Hormone Rece...mentioning
confidence: 99%
“…We have developed a series of thieno[2,3-d]-pyrimidine derivatives with the properties of allosteric agonists and (or) ago-PAMs and allosteric antagonists of LHR [ 324 , 325 , 394 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 ]. Compounds TP03 and TP04, the most active of the full agonists, stimulated the AC activity in testicular membranes isolated from the rat testes, increased testosterone production by the cultured Leydig cells, and also stimulated testicular steroidogenesis and increased testosterone levels when administered intraperitoneally, subcutaneously, and orally to both healthy male rats and animals with androgen deficiency caused by types 1 and 2 diabetes mellitus and aging [ 395 , 400 , 402 , 403 , 404 ]. Using molecular docking, it was found that the efficiency and selectivity of the studied thieno[2,3-d]-pyrimidines correlate with the characteristics of their binding to the transmembrane allosteric site of LHR, and the key parameter of such binding was the intensity of hydrophobic contact while the Coulomb interactions and hydrogen bonds were less significant [ 400 ].…”
Section: Allosteric Regulators Of Pituitary Glycoprotein Hormone Rece...mentioning
confidence: 99%
“…Nevertheless, some thiazolidine analogs may exhibit biased signaling and mobilize either Gα s , Gα i or both. Similarly, recent in vivo studies have identified TP22 21 and Org43553 22 both of which are thieno[2,3-d]pyrimidine compounds as effective allosteric agonists of LHRs but might potentially influence different signal cascades downstream.…”
Section: Introductionmentioning
confidence: 99%